Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma

This study has been completed.

Study NCT00065351 Information provided by Celgene Corporation

First Received: July 21, 2003 Last Updated: September 22, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2007
Primary Completion Date:	October 2006 (Final data collection date for primary outcome measure)